Melanie Senior and Ellen Foster Licking
Pfizer Inc.'s January 25 announcement that it was aligning with seven New York City-based medical centers to discover novel...
Back To School: Big Pharmas Test New Models For Tapping Academia
Pfizer's ambitious tie-ups with multiple research institutions across several cities is but the latest model of academic-industry collaboration, highlighting pharma's ongoing hunger for fresh approaches to drug discovery.
More from Business Strategy
More from In Vivo
• By
Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.
• By
While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.
• By
UK biotech targets the root cause of metabolic disease while preserving muscle mass in a crowded obesity market.